DOCA-PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DOCA-PHARMA
Largest movements
- Cash -€37,107
down €37,107 (-96.8%), from €38,344 to €1,237
mainly Net result for the year (-€64,546) and Stocks and contracts (-€25,658)
- Stocks and contracts +€25,658
new in 2025: €25,658
- Receivables within one year -€5,621
no longer reported in 2025 (was €5,621)
of which Other amounts receivable: -€5,093
- Tangible fixed assets -€2,632
down €2,632 (-6.0%), from €43,817 to €41,185
of which Furniture and vehicles: -€7,784
- Deferred charges and accrued income +€2,553
new in 2025: €2,553
- Profit (loss) carried forward -€64,546
down €64,546 (-319.4%), from -€20,208 to -€84,753
- Current portion of long-term debt +€50,000
new in 2025: €50,000
- Debts after one year -€10,000
down €10,000 (-10.0%), from €100,000 to €90,000
- Tax, wage and social debts +€4,111
up €4,111 (+702.6%), from €585 to €4,696
of which Remuneration and social security: +€3,041
- Advances received +€3,930
new in 2025: €3,930
- Staff costs +€24,104
new in 2025: €24,104
- Depreciation +€10,917
up €10,917 (+788.9%), from €1,384 to €12,300
- Gross operating margin -€8,628
down €8,628 (-46.0%), from -€18,752 to -€27,380
- Financial charges +€650
up €650 (+2992.6%), from €22 to €672
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €89,282 | €72,384 | -€16,899 | -18.9% |
| Fixed assets | 21/28 | €45,317 | €42,935 | -€2,382 | -5.3% |
| Tangible fixed assets | 22/27 | €43,817 | €41,185 | -€2,632 | -6.0% |
| Plant, machinery and equipment | 23 | €732 | €5,885 | +€5,152 | +703.6% |
| Furniture and vehicles | 24 | €43,085 | €35,301 | -€7,784 | -18.1% |
| Financial fixed assets | 28 | €1,500 | €1,750 | +€250 | +16.7% |
| Current assets | 29/58 | €43,965 | €29,448 | -€14,517 | -33.0% |
| Stocks and contracts in progress | 3 | - | €25,658 | +€25,658 | |
| Stocks | 30/36 | - | €25,658 | +€25,658 | |
| Amounts receivable within one year | 40/41 | €5,621 | - | -€5,621 | |
| Trade receivables | 40 | €528 | - | -€528 | |
| Other amounts receivable | 41 | €5,093 | - | -€5,093 | |
| Cash at bank and in hand | 54/58 | €38,344 | €1,237 | -€37,107 | -96.8% |
| Deferred charges and accrued income | 490/1 | - | €2,553 | +€2,553 | |
| Total equity and liabilities | 10/49 | €89,282 | €72,384 | -€16,899 | -18.9% |
| Equity | 10/15 | -€15,208 | -€79,753 | -€64,546 | -424.4% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€20,208 | -€84,753 | -€64,546 | -319.4% |
| Amounts payable | 17/49 | €104,490 | €152,137 | +€47,647 | +45.6% |
| Amounts payable after more than one year | 17 | €100,000 | €90,000 | -€10,000 | -10.0% |
| Financial debts | 170/4 | €100,000 | €90,000 | -€10,000 | -10.0% |
| Amounts payable within one year | 42/48 | €4,490 | €62,137 | +€57,647 | +1284.0% |
| Current portion of amounts payable after more than one year | 42 | - | €50,000 | +€50,000 | |
| Trade debts | 44 | €812 | €1,696 | +€884 | +108.8% |
| Suppliers | 440/4 | €812 | €1,696 | +€884 | +108.8% |
| Advances received on contracts in progress | 46 | - | €3,930 | +€3,930 | |
| Taxes, remuneration and social security | 45 | €585 | €4,696 | +€4,111 | +702.6% |
| Taxes | 450/3 | €585 | €1,656 | +€1,070 | +182.9% |
| Remuneration and social security | 454/9 | - | €3,041 | +€3,041 | |
| Other amounts payable | 47/48 | €3,092 | €1,815 | -€1,278 | -41.3% |
| Remuneration, social security and pensions | 62 | - | €24,104 | +€24,104 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,384 | €12,300 | +€10,917 | +788.9% |
| Other operating charges | 640/8 | €50 | €90 | +€40 | +79.8% |
| Gross operating margin | 9900 | -€18,752 | -€27,380 | -€8,628 | -46.0% |
| Operating profit (loss) | 9901 | -€20,186 | -€63,874 | -€43,688 | -216.4% |
| Financial charges | 65/66B | €22 | €672 | +€650 | +2992.6% |
| Recurring financial charges | 65 | €22 | €672 | +€650 | +2992.6% |
| Profit (loss) for the period before taxes | 9903 | -€20,208 | -€64,546 | -€44,338 | -219.4% |
| Profit (loss) for the period | 9904 | -€20,208 | -€64,546 | -€44,338 | -219.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€20,208 | -€64,546 | -€44,338 | -219.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.